Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HPV testing and cervical cancer screening: recommendations and practice patterns.

Lindsay M Madom1, Lori A Boardman

  • 1Brown Medical School, USA. lboardman@wihri.org

Medicine and Health, Rhode Island
|December 16, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What Is New in Human Papillomavirus-Related Lower Anogenital Tract Disease Prevention and Screening?: Best Articles From the Past Year.

Obstetrics and gynecology·2015
Same author

Screening for Anal Cancer in Women.

Journal of lower genital tract disease·2015
Same author

Clinical recommendation: pediatric lichen sclerosus.

Journal of pediatric and adolescent gynecology·2014
Same author

What is new in hormonal management and menopause?: Best articles from the past year.

Obstetrics and gynecology·2014
Same author

Screening adolescents and young women.

Obstetrics and gynecology clinics of North America·2013
Same author

Barriers to completion of desired postpartum sterilization.

Rhode Island medical journal (2013)·2013

Cervical cancer screening guidelines are evolving with human papillomavirus (HPV) testing. While HPV tests offer reassurance when negative, optimal management for persistent positive HPV results, especially with normal cytology, requires further research.

Area of Science:

  • Gynecologic oncology
  • Infectious disease epidemiology
  • Preventive medicine

Background:

  • Cervical cancer screening guidelines are dynamic, influenced by expanding knowledge of disease pathogenesis.
  • The role of oncogenic human papillomavirus (HPV) in cervical cancer development is increasingly understood.
  • Current screening practices are adapting to incorporate advancements in HPV detection.

Purpose of the Study:

  • To review the evolving landscape of cervical cancer screening.
  • To assess the current role and future potential of oncogenic HPV typing in screening and follow-up.
  • To identify knowledge gaps in managing positive HPV test results, particularly in conjunction with cytology.

Main Methods:

  • Review of current literature and guidelines on cervical cancer screening.

Related Experiment Videos

  • Analysis of the utility of HPV typing in different clinical scenarios.
  • Identification of areas requiring further investigation through prospective studies.

    • Main Results:

    • Oncogenic HPV typing is effective for cervical cancer screening and follow-up in specific contexts.
    • Negative HPV tests provide reassurance to patients and healthcare providers.
    • Long-term management strategies for persistently positive HPV tests, especially with negative cytology, remain unclear.

    Conclusions:

    • HPV testing is a valuable tool in cervical cancer screening, with expanding applications.
    • Further research, including prospective worldwide studies, is crucial to establish optimal management protocols for women with persistent HPV positivity.
    • Continued evolution of screening guidelines is expected as more data on HPV's role becomes available.